Article Text

PDF
NEWS

Statistics from Altmetric.com

California Institute for Regenerative Medicine Awards $75.7 Million to Fund Stem Cell Research

The Independent Citizens Oversight Committee, the governing board of the California Institute for Regenerative Medicine, recently approved 29 Comprehensive Research Grants totaling approximately $75 million over 4 years in support of human embryonic stem cell research. The awards come more than 2 years after California voters approved a $3 billion initiative to fund stem cell research in the state. Investigators at 11 academic and nonprofit research centers throughout the state were chosen to receive funding out of an application pool of 70. Unlike the Leon J. Thal SEED grants awarded earlier this year, which aimed at attracting novel ideas and new researchers to the field of human embryonic stem cell research, the most recent awards will fund accomplished scientists in the field, working on advanced, ongoing studies. A complete listing of principal investigators to receive Comprehensive Research Grants, along with their home institutions and project descriptions, can be found at <http://www.cirm.ca.gov/>.

National Institute of Allergy and Infectious Diseases Names Key New Components of HIV / AIDS Research Networks

The National Institute of Allergy and Infectious Diseases (NIAID) recently selected 60 institutions worldwide to serve as human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) Clinical Trials Units (CTUs) in a newly restructured system of six HIV/AIDS clinical research networks. The six networks are the AIDS Clinical Trials Group, the HIV Prevention Trials Network, the HIV Vaccine Trials Network, the International Maternal Pediatric Adolescent AIDS Clinical Trials Network, the International Network for Strategic Initiatives in Global HIV Trials, and the Microbicide Trials Network. Specific priorities of the CTUs include the development of a safe and effective HIV vaccine, optimization of the clinical management of HIV/AIDS, and the development of microbicides to prevent HIV acquisition and transmission. Each CTU is a member of at least one of these networks, and each CTU will include a principal investigator, an administrative component, a community advisory board, and one or more clinical …

View Full Text

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.